Researcher
Claude Libert
- Keywords (Ghent University):sepsis
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Adaptive immunology, Bacteriology
- Disciplines (Ghent University):Epigenetics, Animal genetics, Autoimmunity, Clinical genetics and molecular diagnostics, Immunogenetics, Innate immunity, Transplantation immunology, Genetics, Applied immunology, Gastro-enterology and hepatology not elsewhere classified, Genome structure and regulation, Quantitative genetics, Endocrinology and metabolic diseases not elsewhere classified
- See also: Claude Libert (Flanders Institute for Biotechnology)
Affiliations
- Libert Lab (Research group)
Responsible
From1 Jan 2017 → Today - Department of Biomedical molecular biology (Department)
Member
From1 Oct 1996 → Today - Department of Plant Biotechnology and Bioinformatics (Department)
Member
From1 Jan 1993 → 30 Sep 1996
Projects
1 - 10 of 67
- Investigating the role of hemolysis in polymicrobial sepsis.From1 Nov 2023 → TodayFunding: FWO fellowships
- Integrative interactome and protein modification analysis of HNF4α in sepsisFrom1 Nov 2023 → TodayFunding: FWO fellowships
- Investigating the protective role of the glucocorticoid receptor against lactate-mediated lethal shock in sepsisFrom1 Oct 2023 → TodayFunding: FWO junior postdoctoral fellowship
- Investigating the role of hemolysis in polymicrobial sepsis.From1 Oct 2023 → 31 Oct 2023Funding: BOF - doctoral mandates
- The role of HNF4α and hepatocyte de-differentiation in sepsisFrom1 Oct 2022 → TodayFunding: BOF - mobility
- Taking IBD Genes from GWAS to Function to Drug TargetFrom1 Jan 2022 → TodayFunding: FWO EOS
- Investigating the role of lactate-mediated lethal shock in sepsis.From1 Nov 2021 → TodayFunding: FWO fellowships
- Understanding the role of nuclear receptor HNF4a in sepsis and unravel the mechanisms of its loss-of-function in relation to PPARa failure.From1 Nov 2021 → TodayFunding: FWO fellowships
- STOP_SEPSIS: investigation into a new concept of sepsis, the greatest unmet medical need of our times.From1 Oct 2021 → TodayFunding: FWO Strategic Basic Research (SBO)
- STOP SEPSISFrom1 Jan 2021 → TodayFunding: BOF - Methusalem
Publications
191 - 200 of 205
- Hop bitter acids efficiently block inflammation independent of GRα, PPARα, or PPARγ(2009)
Authors: Marjan Van Cleemput, Arne Heyerick, Claude Libert, Katrien Swerts, Jan Philippé, Denis De Keukeleire, Guy Haegeman, Karolien De Bosscher
Pages: 1143 - 1155 - Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17(2009)
Authors: Melba Munoz, Markus M Heimesaat, Kerstin Danker, Daniela Struck, Uwe Lohmann, Rita Plickert, Stefan Bereswill, Andre Fischer, Ildiko Rita Dunay, Kerstin Wolk, et al.
Pages: 3047 - 3059 - Spray-dried powders of starch and crosslinked poly(acrylic acid) as carriers for nasal delivery of inactivated influenza vaccine(2009)
Authors: Delphine Coucke, Michael Schotsaert, Claude Libert, Eveline Pringels, Chris Vervaet, P Foreman
Pages: 1279 - 1286 - N-glycan profiles as tools in diagnosis of hepatocellular carcinoma and prediction of healthy human ageing(2009)
Authors: Valerie Vanhooren, Xue-En Liu, Claudio Franceschi, Chun-Fang Gao, Claude Libert, Roland Contreras
Pages: 92 - 97 - Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo(2009)
Authors: S Momi, E Falcinelli, S Giannini, L Ruggeri, L Cecchetti, T Corazzi, Claude Libert, P Gresele
Pages: 2365 - 2379 - In vitro and in vivo protein-bound tyrosine nitration characterized by diagonal chromatography(2009)
Authors: Bart Ghesquière, Niklaas Colaert, Kenny Helsens, Lien Dejager, Caroline Vanhaute, Katleen Verleysen, Evy Timmerman, Marc Goethals, Claude Libert, Joël Vandekerckhove
Pages: 2642 - 2652 - N-Glycan profiling in the study of human aging(2008)
Authors: Valerie Vanhooren, Wouter Laroy, Claude Libert, Cuiying Chen
Pages: 351 - 356 - Over-expression of heat shock protein 70 in mice is associated with growth retardation, tumor formation, and early death(2008)
Authors: Valerie Vanhooren, Xue-En Liu, Liesbeth Desmyter, Ye-Dong Fan, Lieve Vanwalleghem, Wim Van Molle, Sylviane Dewaele, Marleen Praet, Roland Contreras, Claude Libert
Pages: 1013 - 1020 - In-vitro and in-vivo evidence for the anti-inflammatory activity of hop bitter acids in mouse(2008)Volume: 74
Authors: Marjan Van Cleemput, Arne Heyerick, Claude Libert, Denis De Keukeleire, Guy Haegeman, Karolien De Bosscher
Pages: 978 - 979 - IL-17 produced by Paneth cells drives TNF-induced shock(2008)
Authors: N TAKAHASHI, Ineke Vanlaere, Riet De Rycke, Anje Cauwels, LAB JOOSTEN, E LUBBERTS, WB VAN DEN BERG, Claude Libert
Pages: 1755 - 1761
Patents
1 - 1 of 1
- Means and methods to treat inflammation (Inventor)